Teva Pharmaceutical Industries Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Teva Pharmaceutical Industries Ltd.
In a busy second quarter for Teva, a COVID-19 slump acted as a correction to the related boost in demand seen in the first quarter of 2020.
ANI Pharmaceuticals has chosen its new president and CEO to replace interim chief Patrick Walsh who stepped in after the departure Arthur Przybyl earlier this year. Meanwhile, key personnel announcements have also been made by Teva and Mylan.
Teva says it remains hopeful that it can resolve US price-fixing allegations “in a positive way” with the US Department of Justice, but acknowledges that the matter could go all the way to trial.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
- Generic Drugs
- OTC, Consumer
- Other Names / Subsidiaries
- ABIC Marketing Limited
- Auspex Pharmaceuticals, Inc. (Imphar AG)
- Barr Pharmaceuticals
- Bentley Pharmaceuticals
- BioGeneriX AG
- BioAssets Development Corporation
- Cephalon, Inc. (Arana Therapeutics (Peptech and EvoGenix)
- Ception Therapeutics
- ChemGenex Pharmaceuticals Limited
- CIMA Labs
- Gemin X Pharmaceuticals
- CT Arzneimittel GmbH
- Gecko Health Innovations
- IVAX Corporation
- Labrys Biologics
- MicroDose Therapeutx Inc.
- Neose Technologies, Inc.
- NuPathe, Inc.
- PLIVA HRVATSKA d.o.o.
- ratiopharm Group
- Sicor Biotech
- Representaciones e Investigaciones Médicas, S.A. de C.V.
- Taiyo Pharmaceutical Industry Co. Ltd.
- Teva Branded Pharmaceutical Products, R&D Inc.
- Teva Women's Health, Inc.
- Actavis Generics
- Anda, Inc.
- Uteron Pharma S.P.R.L.
- Teva Takeda Yakuhin Ltd.
- Teva Takeda Pharma Ltd.
- Teva Neuroscience, Inc.
- Teva Pharmaceuticals USA, Inc.
- Zeneus Pharma